Clinical trial Recruiting at 2 sites Interventional Ages 65 and up

See if an interprofessional health needs assessment improves quality of life for older adults living at home

Official title: Implementing and Evaluating the Impact of Interprofessional Health Needs Assessment (INHA) for Older Adults Living at Home

Run by University of Stavanger · NCT07686172 · Data updated 2026-11-12

This randomized trial tests whether an interprofessional health needs assessment helps people 65 and older living at home have better health-related quality of life and use health services more appropriately.

More Health Related Quality of Life trials

Quick facts

Study typeInterventional
Ages65 Years and up
SexAll
Enrollment200 (estimated)
SponsorUniversity of Stavanger
Academic / other
Locations2 sites (Sandnes and 1 other locations)
StatusRecruiting
StartedMarch 10, 2026
Main results expectedDecember 31, 2028
Study endsJune 30, 2029
Registry record updatedJuly 8, 2026
Trial IDNCT07686172 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Candidates are people aged 65+ applying for home-based health and care services (e.g., practical help, home nursing, devices, rehabilitation) with expected service duration over two weeks.

Probably not a fit

Individuals under 65, those with dementia, life expectancy under six months, or seeking nursing home placement may not benefit from IHNA as studied.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The study tests the Interprofessional Health Needs Assessment (IHNA) in older adults living at home to see its effect on health-related quality of life, social care-related quality of life, survival, and health service use. Participants are 65 or older, applying for municipal home services, and have a guaranteed duration of more than two weeks. The intervention integrates input from multiple healthcare professionals and the older adult’s preferences, using structured screening tools to identify and address health and social needs. The trial is conducted in two Norwegian municipalities and compares IHNA with standard practice in a randomized controlled design. Primary outcome is health-related quality of life at 12 months; secondary outcomes include social care-related quality of life, time to death, health service utilization, and quality-adjusted life years at 6 and 12 months.

Why it matters

Potential benefit: If successful, IHNA could lead to better-aligned services and improved quality of life for home-dwelling older adults.

How similar studies have gone: Previous work suggests structured, interprofessional assessments can improve care planning, but this exact IHNA approach is being evaluated in this setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 65 years and older
* applying for a municipal health and care service at home (i.e., practical assistance, home nursing, assistive devices, rehabilitation, day care center)
* the health care service will have a duration of more than 2 weeks

Exclusion Criteria:

* younger than 65 years
* diagnosed with dementia
* life expectancy shorter than 6 months
* applying for a nursing home placement

Where it's running

  • Sandnes Municipality
    Sandnes, Norway
    Recruiting
  • Stavanger Muncipality
    Stavanger, Norway
    Recruiting

Study contacts

  • Study coordinator: Arnt Egil Ydstebø

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.